M S Hershfield - Concepedia

Author

M S Hershfield

Duke Medical Center

Also Known As

M HERSHFIELD, M Hershfield, M S Hershfield, M. S. Hershfield, M.S. HERSHFIELD, M.S. Hershfield, Mike Hershfield

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Duke University Hospital Duke University Howard Hughes Medical Institute University of California San Diego

About

M S Hershfield is an author at Duke Medical Center specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	1.5K
2	Natural Sciences	5	5	383
3	Allergy	5	5	426
4	Engineering	2	2	285
5	Health Sciences	1	1	24

M S Hershfield

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine. M S Hershfield Journal of Biological Chemistry	1979	277
Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. L R Finger, Jacob Kagan, G.K. Christopher, Proceedings of the National Academy of Sciences EngineeringCytogeneticsMixed-phenotype Acute LeukemiaGeneticsT-cell Leukemia	1989	227
Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. Rebecca H. Buckley, Sherrie E. Schiff, Hugh A. Sampson, The Journal of Immunology Cell TherapyLymphocyte DevelopmentImmunologyImmune RegulationPathology	1986	195
In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients. M S Hershfield, Nicholas M. Kredich, Dennis R. Ownby, Journal of Clinical Investigation Aldehyde DehydrogenaseCellular EnzymologyBiochemistryVivo InactivationSimilar Inactivation	1979	168
Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. M S Hershfield PubMed	1998	128
Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells. M S Hershfield, J E Fetter, William Small, Journal of Biological Chemistry Oncogenic AgentAdenosine KinaseApoptosisStem Cell ToxicologyCell Death	1982	123
IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency. Sara Chaffee, Ann Mary, E. Richard Stiehm, Journal of Clinical Investigation Immunocytochemical TechniqueImmunodeficienciesImmunologyPathologyImmunotherapy	1992	113
Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. M S Hershfield, Sara Chaffee, Lillian Koro-Johnson, Proceedings of the National Academy of Sciences GlycobiologyMolecular BiologyProtein SynthesisPolyethylene GlycolProtein Expression	1991	105
Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation. Michael P. Davey, Kathleen F. Bongiovanni, W Kaulfersch, Proceedings of the National Academy of Sciences Hematological MalignancyLymphoid NeoplasiaLymphocyte DevelopmentMixed-phenotype Acute LeukemiaGenetics	1986	98
Regulation of de novo purine synthesis in human lymphoblasts. Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase activity. M S Hershfield, J. Edwin Seegmiller Journal of Biological Chemistry Purine SynthesisDevelopmental BiologySignal TransductionProtein ExpressionHuman Growth	1977	96

Page 1